Optivise Advisory Services’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,293
Closed -$210K – 239
2026
Q2
$210K Sell
2,293
-223
-9% -$19.5K 0.11% 211
2026
Q1
$214K Sell
2,516
-442
-15% -$39.4K 0.13% 175
2025
Q4
$234K Buy
2,958
+236
+9% +$18.5K 0.13% 168
2025
Q3
$218K Sell
2,722
-1,542
-36% -$132K 0.13% 176
2025
Q2
$388K Buy
4,264
+103
+2% +$9.4K 0.2% 113
2025
Q1
$390K Sell
4,161
-20
-0.5% -$1.79K 0.22% 103
2024
Q4
$380K Buy
4,181
+224
+6% +$21.4K 0.2% 107
2024
Q3
$411K Sell
3,957
-351
-8% -$35.8K 0.22% 95
2024
Q2
$418K Buy
+4,308
New +$397K 0.23% 95

Other funds holding CL

Optivise Advisory Services's CL Position: Q3 2026 in Review

Optivise Advisory Services sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 2,293 shares — an estimated $210K sold.

Optivise Advisory Services first reported a position in CL in Q2 2024 and held it in 9 quarters. The position peaked at $418K in Q2 2024. 593 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Optivise Advisory Services reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Optivise Advisory Services sold 2,293 Colgate-Palmolive shares in Q3 2026, an estimated $210K.
  • Optivise Advisory Services first reported a position in Colgate-Palmolive in Q2 2024 and held it in 9 quarters.
  • Optivise Advisory Services's Colgate-Palmolive position peaked at $418K in Q2 2024.
  • 593 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Optivise Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.